Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Blephasol
- Development stage
- Unknown
- Lead developer
- Théa Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Blephasol is a preservative-free micellar lotion designed for the daily hygiene of sensitive eyelids and eyelid margins. Developed by Laboratoires Théa, it is specifically formulated to remove sebum, crusts, and debris associated with blepharitis, meibomian gland dysfunction (MGD), and seborrheic dermatitis of the eyelids. The formulation utilizes micellar technology to gently cleanse without the need for rinsing, making it suitable for contact lens wearers and individuals with sensitive skin or eyes. It is often used as part of a management regimen for dry eye syndrome and eyelid inflammation to maintain ocular surface health.
- Brand names
- Blephasol
Beyond the preview
Go deeper on Blephasol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Blephasol.